Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1465 Articles

Jon C. Ogg | Oct 19, 2019 at 6:45 AM EDT

How Biotech and Big Pharma Have Upside Heading Into Earnings

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.

Jon C. Ogg | Oct 17, 2019 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences,…

Chris Lange | Oct 10, 2019 at 9:40 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The September 30 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Oct 10, 2019 at 7:05 AM EDT

5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Microsoft, Intel and Pfizer above all other Dow stocks.

Lee Jackson | Sep 30, 2019 at 7:30 AM EDT

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

The last thing investors want is a value trap loser that stays stagnant, but all these top companies have solid…

Chris Lange | Sep 27, 2019 at 9:55 AM EDT

Good News for Teens Suffering Atopic Dermatitis

Pfizer has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib, in patients aged 12 and…

Chris Lange | Sep 25, 2019 at 9:20 AM EDT

Short Sellers Grow More Selective in Big Pharma

The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Trey Thoelcke | Sep 25, 2019 at 6:35 AM EDT

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Sep 12, 2019 at 6:50 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.

Chris Lange | Aug 27, 2019 at 8:35 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Aug 27, 2019 at 6:35 AM EDT

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Intel, Pfizer and Microsoft above all other Dow stocks.

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:40 AM EDT

Major Pharma Sees Rising Tide in Short Interest

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Aug 12, 2019 at 6:35 AM EDT

Pfizer Once Again the Most Shorted Dow Stock

As of the most recently reported period, short sellers still favored Pfizer, Intel and Microsoft above all other Dow stocks.

1 … 24 25 26 27 28 … 98

Pfizer : PFE

All Pfizer Articles

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Big Pharma Sees Rising Tide in Short Interest

5 Most Shorted Dow Stocks

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

Good News for Teens Suffering Atopic Dermatitis

Short Sellers Grow More Selective in Big Pharma

The 6 Most Shorted Dow Stocks

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

Big Pharma Sees a Rising Tide in Short Interest

The 6 Most Shorted Dow Stocks

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Pfizer Once Again the Most Shorted Dow Stock

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Donald Trump’s Truth Social Stake Hit $4 Billion. Everyday Investors Who Chased the ‘DJT’ Meme Stock Have Watched Billions Evaporate

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Pfizer : PFE

All Pfizer Articles

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Big Pharma Sees Rising Tide in Short Interest

5 Most Shorted Dow Stocks

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

Good News for Teens Suffering Atopic Dermatitis

Short Sellers Grow More Selective in Big Pharma

The 6 Most Shorted Dow Stocks

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

Big Pharma Sees a Rising Tide in Short Interest

The 6 Most Shorted Dow Stocks

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Pfizer Once Again the Most Shorted Dow Stock

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts